Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. (Q54675021)

2 June 2018

title

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. (English)

1 reference

2 June 2018

1 reference

1 reference

2 June 2018

author name string

Jai-Hyun Kim

1 reference

2 June 2018

Tomasz Tuziak

1 reference

2 June 2018

Limei Hu

1 reference

2 June 2018

Zhi Wang

1 reference

2 June 2018

Jolanta Bondaruk

1 reference

2 June 2018

Misook Kim

1 reference

2 June 2018

Colin Dinney

1 reference

2 June 2018

Herbert Barton Grossman

1 reference

2 June 2018

Keith Baggerly

1 reference

2 June 2018

Wei Zhang

1 reference

2 June 2018

Bogdan Czerniak

1 reference

2 June 2018

publication date

1 April 2005

1 reference

2 June 2018

published in

Laboratory Investigation

1 reference

2 June 2018

volume

1 reference

2 June 2018

issue

1 reference

2 June 2018

page(s)

532-549

1 reference

2 June 2018

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Identifying differentially expressed genes in cDNA microarray experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

Filling the void: urinary markers for bladder cancer risk and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Biology and management of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Amplification/overexpression of a mitotic kinase gene in human bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Sequence verification as quality-control step for production of cDNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Tissue microarrays: applications in neuropathology research, diagnosis, and education.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Genetic modeling of human urinary bladder carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700250

7 January 2021

10.1038/LABINVEST.3700250

Identifiers

DOI

1 reference

2 June 2018

Dimensions Publication ID

1017472931

0 references

Fatcat ID

release_mu4gnunt4ffwvohen4sjcvoleq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mu4gnunt4ffwvohen4sjcvoleq

24 November 2022

mapped directly with Wikidata item

1 reference

2 June 2018